Monitoring Agency Report for quarter ended March 31, 2026
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF filed its first Monitoring Agency Report for the IPO completed in February 2026 (₹90 crore fresh issuance + ₹75 crore offer for sale). Of the ₹90 crore gross proceeds, ₹7.72 crore was used for issue expenses, leaving ₹82.28 crore in net proceeds. During Q4 FY26, only ₹8.69 crore was deployed (₹0.97 crore towards general corporate purposes and ₹7.72 crore for issue expenses). As of March 31, 2026, ₹81.31 crore remains unutilized, parked in HDFC Bank fixed deposits earning 7.20–7.27% interest and current accounts. The ₹50 crore allocated for new IVF centre expansion and the ₹20 crore earmarked for debt repayment have not been deployed yet. The monitoring agency (Infomerics Valuation) confirms no deviations from the offer document objects, with the delay attributed to commercial and operational considerations.
No red flags for investors — the monitoring agency certifies proper utilization aligned with the prospectus. However, deployment delays in core capital expenditure (new IVF centres) and debt repayment suggest the company is not in a rush to deploy IPO proceeds, which could delay revenue growth and interest savings. The unutilized funds are safely parked in FDs, mitigating concern about idle cash.